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thens, Greece
OBJECTIVES We examined whether ischemia-modified albumin (IMA) plasma levels change during
exercise stress testing (EST) in patients with known coronary artery disease and whether the
induced changes differ between positive and negative exercise tests.
BACKGROUND Ischemia modified albumin is considered a marker of myocardial ischemia and increases after
coronary angioplasty and in acute coronary syndromes.
METHODS We studied 40 consecutive patients with established coronary artery disease who underwent
EST. Venous samples, for IMA measurement, were collected before the stress test (baseline),
at peak exercise, and 60 min after the completion of the exercise test.
RESULTS There was significant difference in the IMA values at the 3 prespecified time points (p 
0.012), whereas there was no interaction between the IMA changes and the result of the stress
test, whether positive or negative (p for the interaction term 0.94). Baseline, peak EST, and
post-EST IMA levels were similar in patients with positive and negative exercise tests (p 
0.61). The IMA significantly decreased at peak exercise compared with baseline values in
positive (p  0.0001) and in negative EST (p  0.012). Moreover, IMA concentration
increased 60 min after EST compared with peak-EST values in positive (p  0.0001) and in
negative tests (p  0.003), returning to pre-EST levels in both groups.
CONCLUSIONS The IMA plasma levels change significantly during exercise testing in patients with coronary
artery disease, but there is no difference between positive and negative stress tests; this
possibly implies that the observed changes do not reflect myocardial ischemia. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.06.007Cardiol 2006;48:2482–4) © 2006 by the American College of Cardiology Foundation
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Tschemia-modified albumin (IMA) is considered a marker
f myocardial ischemia, in contrast to cardiac enzymes
creatine kinase, creatine kinase-myocardial band [MB],
nd troponins) that are released when cardiac necrosis
ccurs. Ischemia, through hypoxia, acidosis, sodium and
alcium pump disruptions, and free radical injury, might
nduce changes in the binding capacity of the amino
erminus of the albumin to bind metals such as cobalt,
opper, and nickel. Ischemia modified albumin has been
eported to increase after percutaneous coronary interven-
ion (PCI) (1–4) and in acute coronary syndromes (5–7).
e examined whether the IMA plasma levels change
uring exercise stress testing (EST) in patients with known
oronary artery disease and whether the induced changes
iffer between positive and negative exercise tests.
ETHODS
e studied 40 consecutive patients with established coronary
rtery disease who underwent EST as part of their scheduled
linical follow-up; 38 were men, and 2 were women, and their
ge was 59  9 years (range 41 to 75 years). Thirty-two
atients had previous revascularization procedures—PCI or
oronary artery bypass graft—and the remaining 8 had at least
ne80% stenosis on angiography. Ten patients were diabetic
nd 24 were hypertensive; all patients underwent exercise
From the 2nd Department of Cardiology, Onassis Cardiac Surgery Center,
thens, Greece.n
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ccepted September 7, 2006.esting while taking their medications. All patients gave writ-
en informed consent, and the study protocol was approved by
he ethics committee of our hospital.
All patients performed the treadmill exercise test with the
ruce protocol. Peripheral venous samples were collected
efore the stress test (baseline), at peak exercise, and 60 min
fter the completion of the exercise test via an indwelling
atheter. The blood samples were frozen at 70°C and
tored until assayed. Serum IMA was measured with the
lbumin cobalt binding test on an Integra 800 analyzer (Roche,
otkreuz, Switzerland). According to the manufacturer,
xpected values determined in a population of 283 healthy
ndividuals range from 52 to 116 U/ml with a 95th percentile
t 85 U/ml. The total interassay imprecision (coefficient vari-
tion) was 2.7% to 5.7% at 56.3 to 125.9 U/ml for quality
ontrol material. The ESTwas considered as positive when the
atient developed significant ST-segment T-wave changes
2mm ST-segment horizontal or downslopping depression).
tatistical analysis. Data are presented as median values,
ange, and 25th and 75th percentiles. Analysis of variance with
epeated measures was used to test for differences in IMA
evels between time points. Furthermore, the Wilcoxon test
as applied for pairwise comparisons with Bonferroni correction
o account for the inflation in type I error. SPSS statistical software
SPSS Inc., Chicago, Illinois) was used in all data analyses.
ESULTS
wenty-five exercise stress tests were positive, 14 were
egative, and 1 was equivocal and was excluded from further
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December 19, 2006:2482–4 IMA in Exercisenalysis. The IMA levels [median (25th, 75th percentile)]
or all (n  39) patients were: 82 U/ml (78, 87) at baseline,
5 U/ml (69, 81) at peak, and 85 U/ml (79, 91) 60 min after
eak exercise. There was significant difference in the IMA
alues at the 3 prespecified time points (p 0.012), whereas
here was no interaction between the IMA changes and the
esult of the stress test, whether positive or negative (p for
he interaction term  0.94) (Fig. 1). The baseline, peak-
ST, and post-EST IMA levels were similar in patients
ith positive and negative exercise test. The IMA signifi-
antly decreased at peak exercise compared with baseline
alues by 10% in positive (p  0.0001) and by 8% in
egative EST (p  0.012). Moreover, IMA concentration
ncreased 60 min after EST compared with peak-EST
alues by 15% in positive (p  0.0001) and by 13% in
egative tests (p  0.003), returning to pre-EST levels in
oth groups. A highly significant U-shape trend was ob-
erved regarding IMA levels before, at peak, and after EST
p for parapabolic trend 0.001). In addition, IMA con-
entrations did not differ between the 2 groups (positive and
egative) at any of the time points (p  0.61).
ISCUSSION
e found that IMA plasma levels significantly decrease at
eak exercise compared with baseline and return to initial
Abbreviations and Acronyms
EST  exercise stress test
IMA  ischemia-modified albumin
PCI  percutaneous coronary intervention
igure 1. Ischemia-modified albumin levels at baseline, peak exercise stress
esting (EST), and 60 min after EST. Data are presented as median valuesn
nd 25th and 75th percentiles. All peak EST values versus baseline values:
 0.05. All post-EST values versus peak values: p  0.005.alues after 60 min; this occurs similarly in both positive and
egative exercise tests; therefore, it does not seem to reflect
yocardial ischemia and does not increase the diagnostic
alue of EST.
Our results confirm those of a previous report (8) that had
nvestigated IMA kinetics in 38 patients with chest pain and
uspected coronary artery disease undergoing single-proton
mission computed tomography imaging. In that study,
MA levels were also significantly lower at maximum
xercise than baseline and returned to baseline values within
h after stress; this occurred in patients with and without
schemia. Furthermore, IMA levels were similar between
he 2 groups at all time points of the protocol—before
xercise; at maximum exercise; and 1, 2, 3, 4, 5, and 6 h after
xercise. Interestingly, in the same study albumin plasma
evels were also evaluated and found to increase at maximum
xercise, in correlation with IMA decrease, in all patients
ith and without ischemia. Therefore, it seems that the
emoconcentration that occurs during physical exercise
nduces an increase in albumin plasma levels and subse-
uently a decrease in the nonbound portion of a fixed
mount of cobalt. The IMA concentration has also been
hown to decrease immediately post-race compared with
re-race in 19 healthy marathon runners (9). Ischemia-
odified albumin has been evaluated in healthy subjects
fter hand-grip and found to decrease significantly at 1, 3,
nd 5 min after forearm ischemia and return to baseline
hereafter. The same changes were reported for IMA/
lbumin ratio (10). Likewise, in patients with documented
eripheral vascular disease undergoing claudication, limited
readmill test IMA decreased significantly compared with
aseline and returned to baseline at 1 h after stress, although
n this study albumin concentration did not change with
xercise and no correlation was found between IMA and
lbumin levels at any time point (11). In addition, in the
ame study all patients were evaluated with dobutamine
tress echocardiography, which was negative in all; IMA
evels were unchanged at baseline, peak stress, and 1 h after
tress, unlike our negative exercise tests where IMA
hanged significantly and similarly to our positive stress
ests. Still, one should also take into account that
yocardial ischemia during stress test—either physical or
harmacological—might not be as severe as the ischemia
hat occurs during PCI or in the acute coronary syndrome
etting. Because in the latter 2 conditions IMA increases
1–7), it is intriguing that its levels decrease in EST-induced
schemia, as found in our and other studies. Although
peculative, it seems that during EST-induced ischemia, 2
ifferent mechanisms might influence IMA levels; active
schemia tends to increase IMA, but eventually the
emoconcentration mechanism predominates, resulting in
ecreased IMA concentration.
We conclude that IMA plasma levels change significantly
uring exercise testing in patients with coronary artery
isease, but there is no difference between positive and
egative stress test; this might imply that the observed
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IMA in Exercise December 19, 2006:2482–4hanges do not reflect myocardial ischemia. The IMA mea-
urement does not seem to improve the accuracy of EST.
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